Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
Sponsor: Novartis Pharmaceuticals
Summary
The main purpose of this Ph2a study is to evaluate the preliminary efficacy, safety and tolerability of GIA632 when administered to adult participants with moderate to severe atopic dermatitis (AD).
Official title: A Multicenter, Randomized, Participant- and Investigator -Blinded, Placebo-controlled, Phase 2a Study to Assess the Efficacy, Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2025-11-10
Completion Date
2027-09-06
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
GIA632
Active treatment arm
Placebo
Placebo treatment arm
Locations (28)
Ctr for Dermatology Clinical Res
Fremont, California, United States
Aesthetics Skin Care Dermatologic Surgery
Rockville, Maryland, United States
Care Access Hoboken
Hoboken, New Jersey, United States
Novartis Investigative Site
Pleven, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Québec, Quebec, Canada
Novartis Investigative Site
Ostrava, Poruba, Czechia
Novartis Investigative Site
Brno, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Antony, France
Novartis Investigative Site
Dijon, France
Novartis Investigative Site
Martigues, France
Novartis Investigative Site
Nice, France
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Hamburg, Germany
Novartis Investigative Site
Mainz, Germany
Novartis Investigative Site
Ipoh, Perak, Malaysia
Novartis Investigative Site
George Town, Pulau Pinang, Malaysia
Novartis Investigative Site
Kota Kinabalu, Sabah, Malaysia
Novartis Investigative Site
Kuala Lumpur, Malaysia
Novartis Investigative Site
Gdansk, Poland
Novartis Investigative Site
Torun, Poland
Novartis Investigative Site
Warsaw, Poland
Novartis Investigative Site
Singapore, Singapore
Novartis Investigative Site
Singapore, Singapore
Novartis Investigative Site
Singapore, Singapore